Indivior Pharmaceuticals, Inc. (INDV) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Indivio Pharmaceuticals Q1 2026 Financial Results Conference Call and Webcast. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be the question and answer session. To ask a question during the session, you need to press star, one, one on your telephone keypad. You will then hear an automatic message advising your hand is raised. To withdraw a question, please press star, one, and one again. Please be advised that this conference is being recorded. I would now like to hand the conference over to our speaker today, Jason Thompson. Please go ahead. Thanks, Nadia, and welcome to Indivia's first quarter 2026 results conference call. I'm joined today by Joe Schifoni, Chief Executive Officer, Pat Berry, Chief Commercial Officer, Ryan Preba, Chief Financial Officer, and Christian Heidbreder, our Chief Scientific Officer. Before we begin, I need to remind everyone that on today's call, we may make forward-looking statements that are subject to risks and uncertainties, and that actual results may differ materially. We list the factors that may cause our results to be materially different here on slide two of this presentation. We also may refer to non-GAAP measures, the reconciliations for which may also be found in the appendix of this presentation that is now posted on our website at endivere.com. I'll now turn the call over to Joe Schifoni, our CEO. Thanks, Jason. Good morning, and thank you for joining us on today's call to review our first quarter results. I will begin with an overview of our performance and summarize our progress against Phase 2 Accelerate of the Indivior Action Agenda. Pat will discuss sublocate performance, Christian will provide an update on the ...